Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00989-wBi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Iman Abou Dalle Remy Dulery Nour Moukalled Laure Ricard Nicolas Stocker Jean El-Cheikh Mohamad Mohty Ali Bazarbachi Source Type: research
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00985-0Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Karun Neupane Gliceida Galarza Fortuna Riyasha Dahal Timothy Schmidt Rafael Fonseca Rajshekhar Chakraborty Kelly Ann Koehn Meera Mohan Hira Mian Luciano J. Costa Douglas Sborov Ghulam Rehman Mohyuddin Source Type: research
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00986-zGenome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Ram Ajore Jenny Mattsson Maroulio Pertesi Ludvig Ekdahl Zain Ali Markus Hansson Bj örn Nilsson Source Type: research
Genetics and pathologic landscape of lineage switch of acute leukemia during therapy
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00983-2Genetics and pathologic landscape of lineage switch of acute leukemia during therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Ting Zhou Choladda V. Curry Mahsa Khanlari Min Shi Wei Cui Deniz Peker Weina Chen Endi Wang Juehua Gao Qi Shen Wei Xie Fatima Z. Jelloul Rebecca L. King Ji Yuan Xiaoqiong Wang Chen Zhao Ifeyinwa E. Obiorah Elizabeth L. Courville Eric Nomura Sindhu Cherian Source Type: research
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-023-00940-5Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Thomas Roberts Grace Uwenedi Rachel Bruton Graham McIlroy Sarah Damery Panagiota Sylla Nicola Logan Sam Scott May Lau Ahmed Elzaidi Siobhan Plass Soumyajit Mallick Katie Spencer Christine Stephens Christopher Bentley Guy Pratt Jianmin Zuo Shankara Paneesh Source Type: research
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Blood Cancer Journal, Published online: 23 January 2024; doi:10.1038/s41408-024-00979-yPICH deficiency limits the progression of MYC-induced B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 23, 2024 Category: Hematology Authors: Mar ía Castejón-Griñán Eliene Albers Luc ía Simón-Carrasco Paula Aguilera Mauro Sbroggio David Pladevall-Morera Andreas Ingham Ernest Lim Alba Guillen-Benitez Elena Pietrini Michael Lisby Ian D. Hickson Andres J. Lopez-Contreras Source Type: research
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations
Blood Cancer Journal, Published online: 23 January 2024; doi:10.1038/s41408-023-00975-8Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 23, 2024 Category: Hematology Authors: Feng-Ming Tien Chi-Yuan Yao Xavier Cheng-Hong Tsai Min-Yen Lo Chien-Yuan Chen Wan-Hsuan Lee Chien-Chin Lin Yuan-Yeh Kuo Yen-Ling Peng Mei-Hsuan Tseng Yu-Sin Wu Ming-Chih Liu Liang-In Lin Ming-Kai Chuang Bor-Sheng Ko Ming Yao Jih-Luh Tang Wen-Chien Chou Hs Source Type: research
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression?
Blood Cancer Journal, Published online: 23 January 2024; doi:10.1038/s41408-024-00991-2Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 23, 2024 Category: Hematology Authors: Giovanni Barosi Rita Campanelli Paolo Catarsi Carlotta Abb à Adriana Carolei Margherita Massa Robert Peter Gale Vittorio Rosti Source Type: research
Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients
Blood Cancer Journal, Published online: 23 January 2024; doi:10.1038/s41408-024-00987-yPrediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 23, 2024 Category: Hematology Authors: Tiziano Barbui Alessandra Carobbio Source Type: research
Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid
Blood Cancer Journal, Published online: 19 January 2024; doi:10.1038/s41408-024-00984-1Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 19, 2024 Category: Hematology Authors: Charanpreet Singh Manpreet Saini Arihant Jain Deepesh Lad Gaurav Prakash Alka Khadwal Shano Naseem Pankaj Malhotra Source Type: research
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders
Blood Cancer Journal, Published online: 18 January 2024; doi:10.1038/s41408-024-00977-0The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 18, 2024 Category: Hematology Authors: Gianpietro Semenzato Giulia Calabretto Antonella Teramo Vanessa Rebecca Gasparini Elisa Rampazzo Gregorio Baril à Renato Zambello Source Type: research
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience
Blood Cancer Journal, Published online: 18 January 2024; doi:10.1038/s41408-023-00968-7One thousand patients with essential thrombocythemia: the Florence-CRIMM experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 18, 2024 Category: Hematology Authors: Giuseppe G. Loscocco Francesca Gesullo Giulio Capecchi Alessandro Atanasio Chiara Maccari Francesco Mannelli Alessandro M. Vannucchi Paola Guglielmelli Source Type: research
One thousand patients with essential thrombocythemia: the Mayo Clinic experience
Blood Cancer Journal, Published online: 18 January 2024; doi:10.1038/s41408-023-00972-xOne thousand patients with essential thrombocythemia: the Mayo Clinic experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 18, 2024 Category: Hematology Authors: Naseema Gangat Omer Karrar Aref Al-Kali Kebede H. Begna Michelle A. Elliott Alexandra P. Wolanskyj-Spinner Animesh Pardanani Curtis A. Hanson Rhett P. Ketterling Ayalew Tefferi Source Type: research
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study
Blood Cancer Journal, Published online: 18 January 2024; doi:10.1038/s41408-024-00982-3Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 18, 2024 Category: Hematology Authors: Yan-Yan Li Shuai-Shuai Ge Yuan-Hong Huang Ming-Zhu Xu Chao-Ling Wan Kai-Wen Tan Tao Tao Hai-Xia Zhou Sheng-Li Xue Hai-Ping Dai Source Type: research
MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study
Blood Cancer Journal, Published online: 17 January 2024; doi:10.1038/s41408-024-00976-1MRD positivity was the poor prognostic factor for adverse-risk AML patients with allogeneic hematopoietic stem cell transplantation: a multicenter TROPHY study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 17, 2024 Category: Hematology Authors: Yang Cao Wenxuan Huo Jiayu Huang Yang Yang Yu Wang Yingjun Chang Luxiang Wang Zilu Zhang Chuanhe Jiang Xiaoxia Hu Xiaodong Mo Source Type: research
